Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis

OPERA I and OPERA II Clinical Investigators

Research output: Contribution to journalArticlepeer-review

585 Scopus citations

Fingerprint Dive into the research topics of 'Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences